🔴 Park Ha Biological Technology is trading 5.33% down in pre-market after class-action lawsuit draws renewed attention

Park Ha Biological Technology is trading 5.33% down at $2.72 after renewed investor attention around a securities-class-action lawsuit publicized September 24, 2026.

• The complaint alleges misleading business disclosures, a fraudulent stock-promotion scheme, and an artificially low public float.
• No earnings release, corporate announcement, or other verified September 25 catalyst was identified. The broader market is modestly higher, so macro sentiment does not explain the decline.